UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 17, 2009
Commission File Number |
|
Exact Name of Registrant as Specified |
|
IRS Employer |
|
|
|
|
|
1-14756 |
|
Ameren Corporation (Missouri Corporation) 1901 Chouteau Avenue St. Louis, Missouri 63103 (314) 621-3222 |
|
43-1723446 |
|
|
|
|
|
333-56594 |
|
Ameren Energy Generating Company (Illinois Corporation) 1901 Chouteau Avenue St. Louis, Missouri 63103 (314) 621-3222 |
|
37-1395586 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On November 17, 2009, Ameren Energy Generating Company (Genco), issued and sold $250,000,000 principal amount of its 6.30% Senior Notes, Series I, due 2020 (the Notes), pursuant to a Registration Statement on Form S-3 (File No. 333-155416-02), which became effective on November 17, 2008, and a Prospectus Supplement dated November 12, 2009 to a Prospectus dated November 17, 2008. Genco received net offering proceeds of approximately $247.7 million, before expenses. Genco intends to use the net offering proceeds to repay outstanding short-term debt (consisting of borrowings under its revolving credit facilities and/or the non-state-regulated subsidiary money pool of Ameren Corporation, Gencos parent company) incurred to finance capital expenditures and to fund other corporate requirements and for other general corporate purposes. Genco is filing this Current Report on Form 8-K to report as exhibits certain documents in connection with that offering.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
1.1
|
Underwriting Agreement, dated November 12, 2009, between Genco and the several underwriters named therein, for whom Barclays Capital Inc., Morgan Stanley & Co. Incorporated, RBS Securities Inc. and Scotia Capital (USA) Inc. are acting as representatives.
|
4.1*
|
Indenture dated as of November 1, 2000, between Genco and The Bank of New York Mellon Trust Company, N.A., as successor trustee (the Indenture) (incorporated by reference to Exhibit 4.1 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.2* |
First Supplemental Indenture, dated as of November 1, 2000, to the Indenture, relating to Gencos 8.35% Senior Notes, Series B due 2010 (incorporated by reference to Exhibit 4.2 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.3* |
Form of Second Supplemental Indenture, dated as of June 12, 2001, to the Indenture, relating to Gencos 8.35% Senior Notes, Series D due 2010 (incorporated by reference to Exhibit 4.3 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.4* |
Third Supplemental Indenture, dated as of June 1, 2002, to the Indenture, relating to Gencos 7.95% Senior Notes, Series E due 2032 (incorporated by reference to Exhibit 4.1 to Gencos Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2002).
|
4.5* |
Fourth Supplemental Indenture, dated as of January 15, 2003, to the Indenture, relating to Gencos 7.95% Senior Notes, Series F due 2032 (incorporated by reference to Exhibit 4.5 to Gencos Annual Report on Form 10-K for the year ended December 31, 2002).
|
4.6* |
Fifth Supplemental Indenture, dated as of April 1, 2008, to the Indenture, relating to Gencos 7.00% Senior Notes, Series G due 2018 (incorporated by reference to Exhibit 4.2 to Gencos Current Report on Form 8-K, filed April 9, 2008).
|
4.7* |
Sixth Supplemental Indenture to the Indenture, dated as of July 7, 2008, relating to Gencos 7.00% Senior Notes, Series H due 2018 (incorporated by reference to Gencos Registration Statement on Form S-3, filed November 17, 2008 (File No. 333-155416-02)).
|
4.8
|
Seventh Supplemental Indenture, dated as of November 1, 2009, to the Indenture, relating to Gencos 6.30% Senior Notes, Series I, due 2020.
|
5.1
|
Opinion of Craig W. Stensland, Esq., Associate General Counsel of Ameren Services Company, regarding the legality of the Notes (including consent).
|
5.2 and 8 |
Opinion of Morgan, Lewis & Bockius LLP with respect to the Notes (including consent). |
* Incorporated by reference as indicated.
2
This combined Current Report on Form 8-K is being filed separately by Ameren Corporation and Genco (each, a registrant). Information contained herein relating to any individual registrant has been filed by such registrant on its own behalf. No registrant makes any representation as to information relating to any other registrant.
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
AMEREN CORPORATION |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/ Jerre E. Birdsong |
|
|
Jerre E. Birdsong |
|
|
Vice President and Treasurer |
|
|
|
|
|
|
|
AMEREN ENERGY GENERATING COMPANY |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/ Jerre E. Birdsong |
|
|
Jerre E. Birdsong |
|
|
Vice President and Treasurer |
Date: November 17, 2009
4
Exhibit Index
Exhibit No. |
|
Description |
|
|
|
1.1
|
|
Underwriting Agreement, dated November 12, 2009, between Genco and the several underwriters named therein, for whom Barclays Capital Inc., Morgan Stanley & Co. Incorporated, RBS Securities Inc. and Scotia Capital (USA) Inc. are acting as representatives.
|
4.1*
|
|
Indenture dated as of November 1, 2000, between Genco and The Bank of New York Mellon Trust Company, N.A., as successor trustee (the Indenture) (incorporated by reference to Exhibit 4.1 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.2* |
|
First Supplemental Indenture, dated as of November 1, 2000, to the Indenture, relating to Gencos 8.35% Senior Notes, Series B due 2010 (incorporated by reference to Exhibit 4.2 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.3* |
|
Form of Second Supplemental Indenture, dated as of June 12, 2001, to the Indenture, relating to Gencos 8.35% Senior Notes, Series D due 2010 (incorporated by reference to Exhibit 4.3 to Gencos Registration Statement on Form S-4, filed March 6, 2001 (File No. 333-56594)).
|
4.4* |
|
Third Supplemental Indenture, dated as of June 1, 2002, to the Indenture, relating to Gencos 7.95% Senior Notes, Series E due 2032 (incorporated by reference to Exhibit 4.1 to Gencos Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2002).
|
4.5* |
|
Fourth Supplemental Indenture, dated as of January 15, 2003, to the Indenture, relating to Gencos 7.95% Senior Notes, Series F due 2032 (incorporated by reference to Exhibit 4.5 to Gencos Annual Report on Form 10-K for the year ended December 31, 2002).
|
4.6* |
|
Fifth Supplemental Indenture, dated as of April 1, 2008, to the Indenture, relating to Gencos 7.00% Senior Notes, Series G due 2018 (incorporated by reference to Exhibit 4.2 to Gencos Current Report on Form 8-K, filed April 9, 2008).
|
4.7* |
|
Sixth Supplemental Indenture to the Indenture, dated as of July 7, 2008, relating to Gencos 7.00% Senior Notes, Series H due 2018 (incorporated by reference to Gencos Registration Statement on Form S-3, filed November 17, 2008 (File No. 333-155416-02)).
|
4.8
|
|
Seventh Supplemental Indenture, dated as of November 1, 2009, to the Indenture, relating to Gencos 6.30% Senior Notes, Series I, due 2020.
|
5.1
|
|
Opinion of Craig W. Stensland, Esq., Associate General Counsel of Ameren Services Company, regarding the legality of the Notes (including consent).
|
5.2 and 8 |
|
Opinion of Morgan, Lewis & Bockius LLP with respect to the Notes (including consent). |
* Incorporated by reference as indicated.
5